TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF THE ASIA PACIFIC HIGH CONTENT SCREENING MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 39
2.1 MARKETS COVERED 39
2.2 GEOGRAPHICAL SCOPE 40
2.3 YEARS CONSIDERED FOR THE STUDY 41
2.4 CURRENCY AND PRICING 41
2.5 DBMR TRIPOD DATA VALIDATION MODEL 42
2.6 MULTIVARIATE MODELLING 45
2.7 PRODUCT TYPE LIFELINE CURVE 45
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.9 DBMR MARKET POSITION GRID 47
2.10 MARKET APPLICATION COVERAGE GRID 48
2.11 VENDOR SHARE ANALYSIS 49
2.12 SECONDARY SOURCES 50
2.13 ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 53
4.1 PORTER'S FIVE FORCES MODEL 55
5 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: REGULATIONS 56
6 MARKET OVERVIEW, ASIA PACIFIC HIGH CONTENT SCREENING MARKET 58
6.1 DRIVERS 60
6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 60
6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 60
6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 61
6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 62
6.2 RESTRAINTS 62
6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 62
6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 63
6.3 OPPORTUNITIES 64
6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 64
6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 64
6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 65
6.4 CHALLENGES 65
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 65
6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 66
7 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 67
7.1 OVERVIEW 68
7.2 INSTRUMENTS 71
7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 72
7.2.1.1 FIXED 72
7.2.1.2 MOBILE 72
7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 72
7.2.2.1 FIXED 73
7.2.2.2 MOBILE 73
7.2.3 FLOW CYTOMETRY 73
7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 73
7.2.5 MICROPLATE MOVER 73
7.2.6 OTHERS 73
7.3 SOFTWARE 73
7.4 CONSUMABLES 74
7.4.1 REAGENTS & ASSAY KITS 75
7.4.2 MICROPLATES 75
7.4.3 OTHERS 75
7.5 ACCESSORIES 75
7.6 SERVICES 76
8 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY APPLICATION 78
8.1 OVERVIEW 79
8.2 PRIMARY AND SECONDARY SCREENING 82
8.2.1 INSTRUMENTS 83
8.2.2 CONSUMABLES 83
8.2.3 ACCESSORIES 83
8.2.4 SERVICES 83
8.3 TARGET IDENTIFICATION AND VALIDATION 83
8.3.1 INSTRUMENTS 84
8.3.2 CONSUMABLES 84
8.3.3 ACCESSORIES 84
8.3.4 SERVICES 85
8.4 TOXICITY STUDIES 85
8.4.1 INSTRUMENTS 86
8.4.2 CONSUMABLES 86
8.4.3 ACCESSORIES 86
8.4.4 SERVICES 86
8.5 COMPOUND PROFILING 86
8.5.1 INSTRUMENTS 87
8.5.2 CONSUMABLES 87
8.5.3 ACCESSORIES 87
8.5.4 SERVICES 88
8.6 OTHER APPLICATIONS 88
9 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 89
9.1 OVERVIEW 90
9.2 MICROSCOPY 93
9.3 FLOW CYTOMETRY 93
9.4 IMMUNOHISTOCHEMISTRY 94
9.5 MASS SPECTROMETRY 95
9.6 ELISA 96
9.7 WESTERN BLOTTING 97
9.8 OTHERS 97
9.8.1 3D CELL CULTURE MODEL 98
9.8.1.1 STEROIDS 99
9.8.1.2 ORGANOIDS 99
9.8.1.3 TISSUE ON A CHIP 99
9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 99
9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 99
10 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY END USER 100
10.1 OVERVIEW 101
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 104
10.2.1 INSTRUMENTS 104
10.2.2 CONSUMABLES 105
10.2.3 ACCESSORIES 105
10.2.4 SERVICES 105
10.3 CONTRACT RESEARCH ORGANIZATIONS 105
10.3.1 INSTRUMENTS 106
10.3.2 CONSUMABLES 106
10.3.3 ACCESSORIES 106
10.3.4 SERVICES 106
10.4 LABORATORIES 107
10.4.1 INSTRUMENTS 108
10.4.2 CONSUMABLES 108
10.4.3 ACCESSORIES 108
10.4.4 SERVICES 108
10.5 ACADEMIC AND GOVERNMENT INSTITUTES 108
10.5.1 INSTRUMENTS 109
10.5.2 CONSUMABLES 109
10.5.3 ACCESSORIES 109
10.5.4 SERVICES 109
10.6 OTHERS 110
11 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 111
11.1 OVERVIEW 112
11.2 DIRECT TENDERS 115
11.3 RETAIL SALES 115
12 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY REGION 117
12.1 ASIA-PACIFIC 118
12.1.1 JAPAN 130
12.1.2 CHINA 137
12.1.3 INDIA 144
12.1.4 SOUTH KOREA 151
12.1.5 AUSTRALIA 158
12.1.6 NEW ZEALAND 165
12.1.7 SINGAPORE 172
12.1.8 THAILAND 179
12.1.9 MALAYSIA 186
12.1.10 VIETNAM 193
12.1.11 TAIWAN 200
12.1.12 INDONESIA 207
12.1.13 PHILIPPINES 214
12.1.14 REST OF ASIA-PACIFIC 221
13 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 222
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 222
14 ASIA PACIFIC CONTENT SCREENING MARKET, COMPANY PROFILES 223
14.1 THERMO FISHER SCIENTIFIC INC. (2022) 223
14.1.1 COMPANY SNAPSHOT 223
14.1.2 REVENUE ANALYSIS 223
14.1.3 COMPANY SHARE ANALYSIS 224
14.1.4 PRODUCT PORTFOLIO 224
14.1.5 RECENT DEVELOPMENT 224
14.2 BD 225
14.2.1 COMPANY SNAPSHOT 225
14.2.2 REVENUE ANALYSIS 225
14.2.3 COMPANY SHARE ANALYSIS 226
14.2.4 PRODUCT PORTFOLIO 226
14.2.5 RECENT DEVELOPMENTS 226
14.3 PERKINELMER INC. (2022) 227
14.3.1 COMPANY SNAPSHOT 227
14.3.2 REVENUE ANALYSIS 227
14.3.3 COMPANY SHARE ANALYSIS 228
14.3.4 PRODUCT PORTFOLIO 228
14.3.5 RECENT DEVELOPMENTS 229
14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 230
14.4.1 COMPANY SNAPSHOT 230
14.4.2 REVENUE ANALYSIS 230
14.4.3 COMPANY SHARE ANALYSIS 231
14.4.4 PRODUCT PORTFOLIO 231
14.4.5 RECENT DEVELOPMENT 231
14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 232
14.5.1 COMPANY SNAPSHOT 232
14.5.2 REVENUE ANALYSIS 232
14.5.3 COMPANY SHARE ANALYSIS 233
14.5.4 PRODUCT PORTFOLIO 233
14.5.5 RECENT DEVELOPMENT 234
14.6 AGILENT TECHNOLOGIES, INC. (2022) 235
14.6.1 COMPANY SNAPSHOT 235
14.6.2 REVENUE ANALYSIS 235
14.6.3 PRODUCT PORTFOLIO 236
14.6.4 RECENT DEVELOPMENT 236
14.7 ALIGNED GENETICS, INC. (2022) 237
14.7.1 COMPANY SNAPSHOT 237
14.7.2 REVENUE ANALYSIS 237
14.7.3 PRODUCT PORTFOLIO 238
14.7.4 RECENT DEVELOPMENT 238
14.8 ARACELI BIOSCIENCES 239
14.8.1 COMPANY SNAPSHOT 239
14.8.2 PRODUCT PORTFOLIO 239
14.8.3 RECENT DEVELOPMENT 239
14.9 AXXAM S.P.A 240
14.9.1 COMPANY SNAPSHOT 240
14.9.2 PRODUCT PORTFOLIO 240
14.9.3 RECENT DEVELOPMENT 240
14.10 BIO-RAD LABORATORIES, INC. (2022) 241
14.10.1 COMPANY SNAPSHOT 241
14.10.2 REVENUE ANALYSIS 241
14.10.3 PRODUCT PORTFOLIO 242
14.10.4 RECENT DEVELOPMENTS 242
14.11 CARL ZEISS AG 243
14.11.1 COMPANY SNAPSHOT 243
14.11.2 REVENUE ANALYSIS 243
14.11.3 PRODUCT PORTFOLIO 244
14.11.4 RECENT DEVELOPMENT 244
14.12 CORNING INCORPORATED 245
14.12.1 COMPANY SNAPSHOT 245
14.12.2 REVENUE ANALYSIS 245
14.12.3 PRODUCT PORTFOLIO 246
14.12.4 RECENT DEVELOPMENT 246
14.13 DE NOVO SOFTWARE 247
14.13.1 COMPANY SNAPSHOT 247
14.13.2 PRODUCT PORTFOLIO 247
14.13.3 RECENT DEVELOPMENTS 247
14.14 EVIDENT 248
14.14.1 COMPANY SNAPSHOT 248
14.14.2 PRODUCT PORTFOLIO 248
14.14.3 RECENT DEVELOPMENT 248
14.15 GENEDATA AG 249
14.15.1 COMPANY SNAPSHOT 249
14.15.2 PRODUCT PORTFOLIO 249
14.15.3 RECENT DEVELOPMENT 249
14.16 MERCK KGAA 250
14.16.1 COMPANY SNAPSHOT 250
14.16.2 REVENUE ANALYSIS 250
14.16.3 PRODUCT PORTFOLIO 251
14.16.4 RECENT DEVELOPMENTS 251
14.17 MILTENYI BIOTEC 252
14.17.1 COMPANY SNAPSHOT 252
14.17.2 PRODUCT PORTFOLIO 252
14.17.3 RECENT DEVELOPMENT 253
14.18 SARTORIUS AG 254
14.18.1 COMPANY SNAPSHOT 254
14.18.2 REVENUE ANALYSIS 254
14.18.3 PRODUCT PORTFOLIO 255
14.18.4 RECENT DEVELOPMENTS 255
14.19 SYSMEX CORPORATION 256
14.19.1 COMPANY SNAPSHOT 256
14.19.2 REVENUE ANALYSIS 256
14.19.3 PRODUCT PORTFOLIO 257
14.19.4 RECENT DEVELOPMENT 257
14.20 ZIFO RND SOLUTIONS 258
14.20.1 COMPANY SNAPSHOT 258
14.20.2 PRODUCT PORTFOLIO 258
14.20.3 RECENT DEVELOPMENTS 258
15 QUESTIONNAIRE 259
16 RELATED REPORTS 263

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.